GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Net Income Including Noncontrolling Interests

Labiana Health (XMAD:LAB) Net Income Including Noncontrolling Interests : €-9.11 Mil (TTM As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Labiana Health's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2022 was €-7.49 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2022 was €-9.11 Mil.

Labiana Health Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Labiana Health's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Net Income Including Noncontrolling Interests Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Net Income Including Noncontrolling Interests
1.07 -2.11 -9.11

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Net Income Including Noncontrolling Interests - - -1.62 -7.49

Labiana Health Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-9.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labiana Health Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Labiana Health's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
BOM:521141 BOM:531744 BOM:514400 BOM:539546 BOM:514280 BOM:531223 BOM:532140 BOM:514318 BOM:521131 NSE:VCL ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Website
https://www.labiana.com
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.